IWN
AKBA icon

Independent Wealth Network’s Akebia Therapeutics AKBA Stock Holding History

Independent Wealth Network’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$3.25K – 216
2024
Q1 		$3.25K Buy
+10,000
New +$16K ﹤0.01% 223

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Independent Wealth Network's AKBA Position: Q2 2026 in Review

Independent Wealth Network held its Akebia Therapeutics (AKBA) position steady in Q2 2026 at 13,003 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #340.

Independent Wealth Network first reported a position in AKBA in Q1 2024 and has held it in 10 quarters since. The position peaked at $47.3K in Q2 2025. 171 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Independent Wealth Network held 13,003 shares of Akebia Therapeutics worth $14.8K as of Q2 2026.
  • Independent Wealth Network left its Akebia Therapeutics share count unchanged in Q2 2026.
  • Akebia Therapeutics made up ﹤0.01% of Independent Wealth Network's portfolio in Q2 2026, its #340 holding.
  • Independent Wealth Network first reported a position in Akebia Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Independent Wealth Network's Akebia Therapeutics position peaked at $47.3K in Q2 2025.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Independent Wealth Network's 13F filing for Q2 2026, filed 20 Jul 2026.